Jan Aushadhi Encyclopedia Part 1: The PMBJP Vision & Mission

The Pradhan Mantri Bhartiya Janaushadhi Pariyojana (PMBJP) is not just a government scheme; it is a massive socio-economic intervention aimed at democratizing healthcare in India. This first part explores why the scheme was created, who runs it, and what its ultimate goals are as we head into 2026.

---

1. The Historical Context: The Cost of Survival

For decades, the Indian pharmaceutical market was dominated by branded medicines. While India earned the title “Pharmacy of the World” for its massive export of generics, the domestic market remained trapped in a high-price cycle. Patients were often prescribed expensive branded drugs even when cheaper, equally effective generic alternatives were available.

The Result: Out-of-pocket expenditure on medicines became one of the leading causes of debt and poverty in rural India.

2. Birth of the Vision

The scheme was originally launched in 2008 as the “Jan Aushadhi Scheme” by the Department of Pharmaceuticals. However, it gained massive momentum and was rebranded in 2015-16 as PMBJP to scale the infrastructure and ensure quality control.

The Core Objectives:

• Affordability: To make quality medicines available at affordable prices for all, particularly the poor and disadvantaged.
• Awareness: To reduce the psychological barrier that “quality is proportional to price.”
• Accessibility: To ensure that generic medicines are available in every nook and corner of the country.
• Employment: To create a sustainable business model for young pharmacists and entrepreneurs.

---

3. The Enforcer: PMBI (Pharmaceuticals & Medical Devices Bureau of India)

The PMBJP is implemented by the PMBI, an autonomous society under the Department of Pharmaceuticals, Ministry of Chemicals & Fertilizers.

PMBI acts as the central nodal agency responsible for:

1. Procurement: Sourcing medicines from WHO-GMP certified manufacturers.
2. Logistics: Managing a network of central and regional warehouses.
3. Marketing: Spreading awareness through “Jan Aushadhi Diwas” and social media.
4. Monitoring: Ensuring that Kendras follow strict pricing and ethical guidelines.

---

4. The Scale of Success (2026 Snapshot)

As of May 2026, the scheme has achieved unprecedented milestones:

• 10,000+ Operational Kendras: Spanning across all 700+ districts of India.
• Target 25,000: The government is on track to reach 25,000 stores by March 2027.
• Direct Savings: Citizens have saved cumulative billions of rupees (estimated ₹25,000+ Crore in the last few years) compared to branded market prices.

Conclusion

The vision of Jan Aushadhi is simple: Quality medicines should be a right, not a luxury. By shifting the focus from “brands” to “molecules,” PMBJP has fundamentally altered the healthcare landscape of India.

In the next part, we will dismantle the economics of these “cheap” medicines and see exactly how the price drop of 50-90% is achieved without losing efficacy.

---

Next: Part 2 - Economics & Pricing: The “Brand Tax” Elimination